Pharmacokinetic profile of the synthetic mu-opioid receptor agonist [Lys7]Dermorphin-IRDye(R)800CW and its feasibility as a biomarker for opioid use disorder biorxiv.org/content/10.1101/20

Sign in to participate in the conversation
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.